Walgreens, Boehringer Ingelheim partner to improve diversity in clinical trials Ruchika Sharma5 May 2024 10:00 AM ISTDeerfield: Walgreens and Boehringer Ingelheim have announced a strategic collaboration aimed at optimizing recruitment and making clinical trials...
Boehringer Ingelheim gets USFDA nod for high-concentration, citrate-free formulation of Cyltezo to treat multiple chronic inflammatory diseases Ruchika Sharma2 May 2024 11:30 AM ISTThe high-concentration formulation (100 mg/mL), which is now available as a pre-filled syringe or pre-filled autoinjector.
India becoming attractive for clinical trials: Pharma industry leaders Ruchika Sharma29 April 2024 2:33 PM ISTNew Delhi: Experts from the pharmaceutical sector have noted that over the last decade, clinical trials in India have undergone significant...
Boehringer Ingelheim, Sosei Heptares collaborate to develop first-in-class treatments targeting all symptoms of schizophrenia Ruchika Sharma11 March 2024 9:00 AM ISTIngelheim: Boehringer Ingelheim and Sosei Group Corporation have announced they have entered a global collaboration and exclusive...
Boehringer Ingelheim accused of misusing US patents to delay asthma-drug rivals Ruchika Sharma7 March 2024 12:38 PM ISTGerman drugmaker Boehringer Ingelheim was accused in a federal lawsuit in Boston on Wednesday of improperly submitting patents to the U.S. Food and...
Study Safety and Efficacy of Tenecteplase 0.25 mg/kg in Acute Ischemic Stroke: CDSCO Panel Tells Boehringer Ingelheim Dr. Divya Colin10 Feb 2024 6:00 PM ISTNew Delhi: Rejecting the drug major Boehringer Ingelheim's request for waiver of the local clinical trial of Metalyse 25 mg (tenecteplase 0.25 mg/kg)...
Boehringer expands production site in Greece for new medicine Ruchika Sharma14 Jan 2024 9:00 AM ISTIngelheim: Boehringer Ingelheim, a research-driven biopharmaceutical company, has announced a further expansion and upgrade of its plant in...
Boehringer Ingelheim, 3T Biosciences enter into second partnership for cancer immunotherapies Ruchika Sharma7 Jan 2024 10:00 AM ISTIngelheim: Boehringer Ingelheim and 3T Biosciences have announced they have entered into a new strategic collaboration and licensing agreement...
Boehringer Ingelheim partners with Ribo to develop new treatments for people with liver diseases Ruchika Sharma3 Jan 2024 1:53 PM ISTIngelheim: Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo) have announced a collaboration with Boehringer Ingelheim to...
Boehringer Ingelheim receives approval for Senvelgo in Europe for diabetic cats Ruchika Sharma24 Nov 2023 3:30 PM ISTFeline diabetes mellitus is a metabolic disorder which occurs when a cat has insufficient levels of, or an abnormal response to insulin.
Boehringer Ingelheim expands immuno oncology portfolio with acquisition of bacterial cancer therapy specialist T3 Pharma Ruchika Sharma24 Nov 2023 1:30 PM ISTGermany: Boehringer Ingelheim has announced the acquisition of privately-held T3 Pharmaceuticals AG, a clinical stage Swiss biotech company, for an...
Aldosterone synthase inhibitor shows promise in CKD trial: Boehringer Ingelheim Ruchika Sharma5 Nov 2023 2:30 PM ISTGermany: Boehringer Ingelheim has announced promising 14-week Phase II data for BI 690517, a novel selective aldosterone synthase inhibitor...
